A full year well-aligned with Humana’s objectives

Fourth quarter: October-December 2016

· Operating revenue amounted to SEK 1,681 M (1,521 incl. capital gain of SEK 62 M), an increase of 11% or SEK 160 M.
· Operating profit was SEK 73 M (78). Operating profit adjusted for one-offs was SEK 73 M (60), equivalent to an operating margin of 4.3% (3.9).   
· Net profit after tax for the period was SEK 34 M (47).
· Earnings per share for the period before and after dilution were SEK 0.65 (0.56).
· Operating cash flow was SEK -247 M (197). The change is primarily attributable to changed payment terms in Personal Assistance and increased investments.

Full year: January-December 2016

· Operating revenue amounted to SEK 6,362 M (5,655 including a capital gain of SEK 62 M), an increase of 13% or SEK 707 M.
· Operating profit was SEK 329 M (312), an increase of SEK 17 M. Operating profit adjusted for IPO expenses amounted to SEK 369 M (340 adjusted for items affecting comparability of net SEK -27 M), an adjusted operating margin of 5.8% (6.0). 
· Net profit after tax for the year was SEK 170 M (114).
· Earnings per share for the year before and after dilution were SEK 2.87 M (0.61).
· Operating cash flow was SEK -134 M (390). The change is primarily attributable to changed payment terms in Personal Assistance and increased investments. 

Events during the fourth quarter

· Försäkringskassan transitions from paying in advance to paying in arrears
Försäkringskassan initiated payment in arrears instead of the previous payment in advance as of 1 October 2016. The negative impact on working capital in the fourth quarter was approximately SEK 300 M. The previous estimate of a total impact of SEK 200–300 M remains unchanged. 

Significant events after the end of the period

· The Board proposes a dividend of SEK 0.50 per share to be distributed for 2016
The Board proposes that a dividend of SEK 0.50 per share is to be paid for 2016. The remaining profit for the year is to be carried forward.  

Presentation of report today at 09:00 CET 
To participate in the conference call, and thereby be able to ask questions, please call one of the following numbers:

· SE: +46 8 566 426 62 or
· UK: +44 203 008 98 02 

The presentation material will be published before the conference starts on Humana’s website, http://corporate.humana.se under Investor Relations. 

For further information, please contact: 
Rasmus Nerman, President and CEO, +46 70 828 1860, rasmus.nerman@humana.se
 (cecilia.lannebo@humana.se)Ulf Bonnevier, CFO, +46 70 164 7317, ulf.bonnevier@humana.se (cecilia.lannebo@humana.se)
Cecilia Lannebo, Head of Investor Relations, +46 72-220 82 77, cecilia.lannebo@humana.se